Cognito Therapeutics Raises $73M in Series B Funding - FinSMEs

By FinSMEs. -. March 22, 2023. Cognito Therapeutics, a Cambridge, MA-based neurotechnology company advancing disease-modifying therapies to treat CNS diseases, raised $73M in Series …


Install CouponFollow Chrome Extension   CouponFollow Extension

$73
OFF

Cognito Therapeutics Raises $73M In Series B Funding - FinSMEs

1 week from now

By FinSMEs. -. March 22, 2023. Cognito Therapeutics, a Cambridge, MA-based neurotechnology company advancing disease-modifying therapies to treat CNS diseases, raised $73M in Series …

finsmes.com

$73
OFF

Neurotechnology Company Cognito Therapeutics Scores $73M

1 week from now

March 23, 2023. 09:52 am. Photo courtesy of Cognito Therapeutics. Cognito Therapeutics, a startup using visual and auditory stimulation to treat neurodegenerative disorders, scored $73 …

mobihealthnews.com

$73
OFF

Cognito Therapeutics Raises $73M For Non-invasive Neuromod Tech

1 week from now

Mar 22, 2023  · Cognito Therapeutics announced today that it raised $73 million in a Series B financing round to support its neuromodulation technology. Cambridge, Massachusetts–based …

massdevice.com

$73
OFF

Cognito Therapeutics Raises $73M Series B To Advance …

1 week from now

Cognito Therapeutics Raises $73M Series B to Advance Neurotechnology ...

biospace.com

$73
OFF

Cognito Therapeutics Raises $73M In Series B Funding For …

1 week from now

Mar 23, 2023  · Cognito Therapeutics, a neurotechnology company advancing disease-modifying therapies to treat CNS diseases, has completed a $73M Series B financing round led by …

mpo-mag.com

$73
OFF

Cognito Therapeutics Scores $73m Series B - Venture Capital Journal

1 week from now

Mar 22, 2023  · The funding will advance Cognito’s study of its non-invasive neuromodulation device. Cambridge, Massachusetts-based Cognito Therapeutics, a neurotechnology company …

venturecapitaljournal.com

$73
OFF

Cognito Therapeutics Closes $73M Series B Financing

1 week from now

Mar 23, 2023  · Cognito Therapeutics announced a $73M Series B financing round led by FoundersX Ventures, bringing the total amount raised since inception to $93 million. ... Zeto …

g-medtech.com

$73
OFF

Firm Advises Cognito Therapeutics On $73 Million Series B Financing

1 week from now

Mar 31, 2023  · On March 22, 2023, neurotechnology company Cognito Therapeutics announced a $73 million Series B financing round. The financing was led by FoundersX Ventures with …

wsgr.com

$73
OFF

Cognito Collects $73M For Light-and-sound Alzheimer's Therapy

1 week from now

Mar 22, 2023  · The series B round adds $73 million to Cognito’s coffers, the startup announced Wednesday. It’ll go toward the ongoing pivotal study of the noninvasive headset, which relies …

fiercebiotech.com

$73
OFF

Neurotechnology Company Cognito Therapeutics Scores $73M

1 week from now

Mar 23, 2023  · Originally published by MobiHealthNews on March 23, 2023. Cognito Therapeutics, a startup using visual and auditory stimulation to treat neurodegenerative …

agetech.news

$73
OFF

Series B - Cognito Therapeutics - 2023-03-22 - Crunchbase

1 week from now

Mar 22, 2023  · Built In Boston — Cognito Raises $73M to Combat Alzheimer’s Disease. News • Mar 22, 2023. Business Wire — Cognito Therapeutics Raises $73M Series B to Advance …

crunchbase.com

$73
OFF

Cognito Therapeutics Archives - FinSMEs

1 week from now

FinSMEs The Website About Venture Capital News . USA. UK. ... Italy. Search. Home Tags Cognito Therapeutics. Tag: Cognito Therapeutics. USA. Cognito Therapeutics Raises $73M in …

finsmes.com

$35
OFF

Cognito Therapeutics Raises $35M Series B Extension - VatorNews

1 week from now

The round is an extension of the Series B round the company raised $73 million in March 2023 from FoundersX, Morningside, Alzheimer’s Drug Discovery Foundation, IAG Capital, …

vator.tv

$35000000
OFF

Series B - Cognito Therapeutics - 2024-01-29 - Crunchbase

1 week from now

Jan 29, 2024  · Cognito Therapeutics raised $35000000 on 2024-01-29 in Series B. FoundersX Ventures FoundersX Ventures, a cross-stage venture capital firm based in Menlo Park with …

crunchbase.com

$181
OFF

Alentis Therapeutics Raises $181.4M In Series D Funding

1 week from now

6 days ago  · November 12, 2024. Alentis Therapeutics, a Basel, Switzerland-based clinical-stage biotech company, raised $181.4M in Series D funding. The round was led by OrbiMed, with …

finsmes.com

$50
OFF

EpiBiologics Raises $50M In Series A Financing - FinSMEs

1 week from now

By FinSMEs. -. March 22, 2023. EpiBiologics, a San Mateo, CA-based biotechnology company building a next-generation antibody-based protein degradation platform, raised $50M in Series …

finsmes.com

$20
OFF

Zucara Therapeutics Raises US$20M In Series B Financing

1 week from now

6 days ago  · By FinSMEs. -. November 12, 2024. Zucara Therapeutics, a Toronto, Canada-based diabetes life sciences company, raised US$20M in Series B funding. The round was led by …

finsmes.com

FAQs about Cognito Therapeutics Raises $73M in Series B Funding - FinSMEs Coupon?

Does Cognito therapeutics have a series B financing?

CAMBRIDGE, Mass.-- ( BUSINESS WIRE )-- Cognito Therapeutics, a neurotechnology company advancing disease-modifying therapies to treat CNS diseases, announced today a $73M Series B financing round led by FoundersX Ventures with participation from all existing investors. ...

Who is Cognito Therapeutics?

About Cognito Therapeutics Cognito Therapeutics is a clinical-stage neurotechnology company developing disease-modifying therapeutic approaches to treat neurodegenerative disorders. Its non-invasive neuromodulation platform was developed by MIT Professors and scientific founders Li-Huei Tsai and Ed Boyden. ...

Where is Cognito based?

The Company’s lead therapy is currently in a pivotal study in Alzheimer’s Disease and was awarded FDA Breakthrough Device Designation. Cognito is based in Cambridge, MA. For more information, visit www.cognitotx.com. Follow us on Twitter at @cognitotx. ...

Who will join Cognito's Board of directors?

In addition to the financing, Dr. Rick Kuntz, MD, MSc, former Senior Vice President, Chief Medical and Scientific Officer of Medtronic and Helen Liang, Founder & Managing Partner at FoundersX, will join Cognito’s Board of Directors. Dr. ...

Is Cognito a non-invasive neuromodulation device?

Its non-invasive neuromodulation platform was developed by MIT Professors and scientific founders Li-Huei Tsai and Ed Boyden. The Company’s lead therapy is currently in a pivotal study in Alzheimer’s Disease and was awarded FDA Breakthrough Device Designation. Cognito is based in Cambridge, MA. ...

Does Cognito slow cognitive decline?

In a prior Phase 2 clinical trial, Cognito’s device demonstrated a significant slowing in functional and cognitive decline in the treatment group, as well as a significant decline in brain atrophy over a six-month period. ...

Install CouponFollow Extension on Chrome

Install the CouponFollow extension to search for discount codes when shopping the fastest!

Install CouponFollow Chrome Extension   Install CouponFollow Chrome Extension